Authors: van Praag, RME van Heeswijk, RPG Jurriaans, S Lange, JMA Hoetelmans, RMW Prins, JM

Citation: Rme. Van Praag et al., Penetration of the nucleoside analogue abacavir into the genital tract of men infected with human immunodeficiency virus type 1, CLIN INF D, 33(8), 2001, pp. E91-E92

Authors: van Praag, RME Repping, S de Vries, JWA Lange, JMA Hoetelmans, RMW Prins, JM

Citation: Rme. Van Praag et al., Pharmacokinetic profiles of nevirapine and indinavir in various fractions of seminal plasma, ANTIM AG CH, 45(10), 2001, pp. 2902-2907

Authors: Gisolf, EH van Praag, RME Jurriaans, S Portegies, P Goudsmit, J Danner, SA Lange, JMA Prins, JM

Citation: Eh. Gisolf et al., Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy, J ACQ IMM D, 25(5), 2000, pp. 426-433

Authors: van Praag, RME Weverling, GJ Portegies, P Jurriaans, S Zhou, XJ Turner-Foisy, ML Sommadossi, JP Burger, DM Lange, JMA Hoetelmans, RMW Prins, JM

Citation: Rme. Van Praag et al., Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir, AIDS, 14(9), 2000, pp. 1187-1194

Authors: Prins, JM Jurriaans, S van Praag, RME Blaak, H van Rij, R Schellekens, PTA ten Berge, IJM Yong, SL Fox, CH Roos, MTL de Wolf, F Goudsmit, J Schuitemaker, H Lange, JMA

Citation: Jm. Prins et al., Immune-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy, AIDS, 13(17), 1999, pp. 2405-2410